Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply.
Publication
, Journal Article
Lopes, RD; Vora, AN; Alexander, JH
Published in: JAMA Cardiol
February 1, 2021
Duke Scholars
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
February 1, 2021
Volume
6
Issue
2
Start / End Page
241
Location
United States
Related Subject Headings
- Percutaneous Coronary Intervention
- Humans
- Fibrinolytic Agents
- Atrial Fibrillation
- Anticoagulants
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., Vora, A. N., & Alexander, J. H. (2021). Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply. JAMA Cardiol, 6(2), 241. https://doi.org/10.1001/jamacardio.2020.4759
Lopes, Renato D., Amit N. Vora, and John H. Alexander. “Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply.” JAMA Cardiol 6, no. 2 (February 1, 2021): 241. https://doi.org/10.1001/jamacardio.2020.4759.
Lopes RD, Vora AN, Alexander JH. Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply. JAMA Cardiol. 2021 Feb 1;6(2):241.
Lopes, Renato D., et al. “Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply.” JAMA Cardiol, vol. 6, no. 2, Feb. 2021, p. 241. Pubmed, doi:10.1001/jamacardio.2020.4759.
Lopes RD, Vora AN, Alexander JH. Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply. JAMA Cardiol. 2021 Feb 1;6(2):241.
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
February 1, 2021
Volume
6
Issue
2
Start / End Page
241
Location
United States
Related Subject Headings
- Percutaneous Coronary Intervention
- Humans
- Fibrinolytic Agents
- Atrial Fibrillation
- Anticoagulants
- 3201 Cardiovascular medicine and haematology